New study aims to predict hidden hepatitis b danger in transplant patients
NCT ID NCT07644026
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will develop and test a prediction tool (nomogram) to estimate the risk of hepatitis B virus reactivation in patients who have had a past infection and are undergoing a stem cell transplant. Researchers will follow 300 patients for at least 36 months after transplant, collecting data on reactivation events. No new treatments are being tested; the goal is to create a better way to identify high-risk patients so doctors can monitor them more closely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could give doctors a reliable way to predict which patients are at risk of hepatitis B reactivation after stem cell transplant, helping them take preventive steps.
What could go wrong
This is an observational study that only builds a prediction model, not a treatment. The model may not be accurate enough for all patients, and it won't directly prevent or cure the reactivation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HSCT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••